JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bossolasco, S.
Right arrow Articles by Cinque, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bossolasco, S.
Right arrow Articles by Cinque, P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2003, p. 5080-5084, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5080-5084.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Real-Time PCR Assay for Clinical Management of Human Immunodeficiency Virus-Infected Patients with Visceral Leishmaniasis

Simona Bossolasco,1* Giovanni Gaiera,1 Davide Olchini,1 Maurizio Gulletta,2 Leonardo Martello,1 Arabella Bestetti,1 Laura Bossi,3 Luca Germagnoli,4 Adriano Lazzarin,1 Caterina Uberti-Foppa,1 and Paola Cinque1

Clinic of Infectious Diseases,1 Central Laboratory Analysis, San Raffaele Hospital,4 Central Laboratory Analysis, Ospedale Maggiore, IRCCS, Milan,3 Department of Infectious Disease and Tropical Medicine, Spedali Civili, Brescia, Italy2

Received 30 May 2003/ Returned for modification 28 July 2003/ Accepted 20 August 2003

To evaluate the usefulness of a real-time PCR for Leishmania DNA in the diagnosis and follow-up of patients with human immunodeficiency virus type 1 (HIV-1) and Leishmania coinfection, Leishmania DNA levels were measured in whole peripheral blood from 25 HIV-infected patients with clinical features suggestive of visceral leishmaniasis. Leishmania DNA was detected in 10 of 25 patients with microscopically confirmed visceral leishmaniasis and in none of those without this disease. Following treatment with liposomal amphotericin B, a clinical response was observed in 9 of 10 patients, in association with significantly decreased parasite loads. Seven patients relapsed clinically a median of 110 days after the end of treatment, in association with substantial increases in Leishmania DNA levels. Leishmania DNA levels correlated with the clinical course of visceral leishmaniasis, and their measurement at diagnosis and during and after treatment seems to be useful in the clinical management of HIV-infected patients with this disease.


* Corresponding author. Mailing address: Division of Infectious Diseases, San Raffaele Hospital, Via Stamira d'Ancona, 20, 20127 Milan, Italy. Phone: 39-02-26437985. Fax: 39-02-26437989. E-mail: bossolasco.simona{at}hsr.it.


Journal of Clinical Microbiology, November 2003, p. 5080-5084, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5080-5084.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.